Every year, almost 45.000 people in Ireland are diagnosed with cancer, making Ireland the country with the highest cancer incidence in Europe.
The 5 most diagnosed types of cancer in Ireland are:
- Skin cancer
- Prostate cancer
- Breast cancer
- Bowel cancer
- Lung cancer
1 out of 4 deaths in Ireland can be attributed to cancer, accounting for roughly 30% of all deaths each year.
That makes cancer the dominant cause of death. Therefore, the fight against cancer is of the utmost importance for Ireland’s public health. Experts expect cancer rates in Ireland to rise in the next two to three decades. If conditions remain stable, the number for men could more than double, and the number for women could nearly double. While it is not possible to make an exact prediction decades into the future, these estimates are nonetheless alarming. Similar to other European countries, the most common cancer in men is prostate cancer and breast cancer in women. Bowel, skin, and lung cancer affect both men and women.
Breast cancer has the highest mortality among female cancer patients in Ireland.
Colorectal cancer has one of the highest mortality rates in both men and women in the EU.
There is, however, another important number to be considered: the number of cancer survivors. At this point, more than 173.000 people in Ireland are cancer survivors, that means nearly 4% of the population. Today, 6 out of 10 cancer patients in Ireland are alive 5 years after the initial diagnosis, a significant rise compared to only a few decades ago. In its battle against cancer, Ireland launched a nationwide program to improve cancer care on a systemic level. With efforts to reduce the occurrence of common cancers with preventative measures and campaigns for early detection, there is reason to have hope for the number of survivors to increase even more. Advances in care and technology also significantly impact the prognosis and survival rates. 50%-60% of cancer patients in Ireland receive or could benefit from radiotherapy at some point in their treatment. Therefore, providing the best possible care and radiotherapy treatment options must be a priority.
MVision AI strives to support Irish clinicians and patients in their fight against cancer by helping to make cancer radiotherapy faster, more precise, and therefore safer. As an example, MVision’s prostate cancer auto-segmentation model has shown great promise in retrospective studies. AI and deep-learning-based auto-segmentation and contouring can help clinicians to treat more patients in a shorter amount of time, while also improving the quality of treatment. MVision AI provides high-quality models for radiotherapy for all important cancer indications, as recognised by research and studies.
Ireland has the highest incidence of prostate cancer within the EU.
With the expected rise in cancer cases, providing more time-efficient treatment options without compromising accuracy and effectiveness is a crucial step towards improving the one number we care about the most: the number of cancer survivors.
Are you eager to learn more? We welcome you to contact MVision AI:
c/o Terkko Health Hub, Haartmaninkatu 4, 00290 Helsinki, Finland.
Tel: +358 (0) 40 5489 229
For media inquiries:
+358 40 500 7915; firstname.lastname@example.org
Dyba et al., 2021. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568058/
Kiljunen et al., 2020. https://www.mdpi.com/2075-4418/10/11/959
National Cancer Register Ireland. https://www.ncri.ie/data/survival-statistics and
MVision AI, 2022. https://www.mvision.ai/gbs-abstracts-degro-2022/
NCCP, 2021. https://www.hse.ie/eng/services/list/5/cancer/profinfo/medonc/nccp-systemic-anti-cancer-therapy-model-of-care.pdf and https://www.hse.ie/eng/services/list/5/cancer/patient/treat/radio/whatrt.html
The Global Cancer Observatory, 2021. https://gco.iarc.fr/today/data/factsheets/populations/372-ireland-fact-sheets.pdf